21 December 2009
The reliability of ELISA in predicting H. pylori infection in dyspeptic populations under age 45
Malgorzata PalkaABCDEF, Tomasz TomasikACDG, Adam WindakACDG, Grzegorz MargasABCDE, Tomasz MachACDEG, Agnieszka BohonosEFMed Sci Monit 2010; 16(1): PH24-28 :: ID: 878313
Abstract
Background
Dyspepsia is a common problem worldwide. Many dyspeptic patients have no alarm symptoms and are diagnosed by family doctors. Non-invasive testing of H. pylori is recommended in patients up to the age of 55. Testing of asymptomatic high risk groups is now being considered in many countries. The aim of the study was to compare the accuracy of serology tests (ELISA, HelicoTest) against the benchmark UBT (urea breath test) in the detection of H. pylori infection in young populations.
Material and Method
The study was conducted on 238 patients under age 45 (159 with undiagnosed dyspepsia and 79 controls). The gold standard of diagnosis of H. pylori infection was based on a positive UBT. UBT, serological ELISA and HelicoTest were performed on each of the patients.
Results
By UBT 50.9% and by ELISA 49.7% of dyspeptic patients were infected with H. pylori, while in the control group 38% and 39.2% were infected, respectively. HelicoTest showed the highest positive results in both groups (55.3% study group, 44.3% control). The average level of IgG antibodies from ELISA testing among patients with a positive UBT H. pylori result was 3.16 U/ml. Patients with negative UBT results showed an average IgG level of 0.53 U/ml.
Conclusions
There was a correlation of increasing antibody level on ELISA and probability of testing positive on UBT. The majority of patients had moderate dyspeptic symptoms. The ELISA is an easy, cheap and effective method for diagnosing H. pylori infection in the primary care setting.
Keywords: Immunoglobulin G - analysis, Helicobacter Infections - diagnosis, Helicobacter pylori, Enzyme-Linked Immunosorbent Assay - statistics & numerical data, Dyspepsia - microbiology, Breath Tests - methods, Poland
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical CancerMed Sci Monit In Press; DOI: 10.12659/MSM.945964
Clinical Research
Inflammatory Biomarkers in Smokers: Implications for Ligamentum Flavum HypertrophyMed Sci Monit In Press; DOI: 10.12659/MSM.947508
Clinical Research
Balancing Image Quality and Iodine Intake: Insights from CT Spectral Imaging of the Portal VeinMed Sci Monit In Press; DOI: 10.12659/MSM.947391
Review article
Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.947124
Most Viewed Current Articles
17 Jan 2024 : Review article 7,160,485
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,385
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,806
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 22,071
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912